शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BOROSCIBSEBOROSIL SCIENTIFIC LTD· Industrial ProductsHighNeutral
Announced Mon, 3 Aug, 2026 · 17:57 IST

Q1 FY27: Revenue up 12%, PAT at Rs 6.84 cr vs Rs 0.46 cr YoY

Profit growth above 25%Exceptional itemEBITDA margin expansionResults View source PDFExplain this filing

BOROSCI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.3%Reaction day
₹151.01
prior close
₹153.03
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-3.8% vs market
Industrial Products peers, median of 322sector · industry level+0.1%-3.4% vs sector

On the reaction day the stock moved 3.8 pts less than Nifty Microcap 250 and 3.4 pts less than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-3.4
10m
-2.5
15m
-2.5
30m
-2.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.3+0.4-3.8+0.1-3.4
Next day
-6.3+1.7-8.0+0.5-6.8
2d
-8.5+2.1-10.6+0.5-8.9
3d
-6.1+2.1-8.2+0.3-6.4
4d
-9.3+2.1-11.3+0.8-10.1
5d
-10.1+1.9-12.0+0.5-10.6
1w
-10.4+2.4-12.8+0.5-10.9
15d
-16.8+3.0-19.8+0.5-17.3
1m
-13.3+3.7-17.0+1.9-15.1
2m
-25.8+1.6-27.4-0.3-25.5
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Industrial Products peers, median of 322Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Standalone revenue grew 12% YoY to Rs 99.9 cr (vs Rs 89 cr). PAT jumped to Rs 6.84 cr from Rs 0.46 cr, lifted by absence of one-time VRS expense of Rs 6.6 cr in base quarter. Scientific segment revenue up 6.3%, Glassware up 19.4%. Consolidated revenue at Rs 106.75 cr, PAT Rs 4.35 cr versus loss of Rs 4.21 cr YoY. Board also amended ESOP schemes to allow trust route share allotment and raised discount limit to 20%.

Likely market impact

Strong profit rebound on lower one-time costs. Core growth steady. Wider ESOP discount may dilute shares but aids retention.